The clearly defined genetic and phenotypic stages in the evolution of squamous tumor development on mouse skin provides an opportunity to evaluate mechanisms of carcinogenesis in a stage-specific manner. Focus on genetic changes frequently detected in human cancers such as mutations in ras or p53 and alterations in the epidermal growth factor receptor(EGFR)family is helpful in extrapolating results from the animal model to understand carcinogenesis in humans. Keratinocytes derived from EGFR deficient mice and transformed by the ras oncogene form very small tumors with a high growth fraction in vivo. Studies with these null keratinocytes in vitro reveal an accelerated migration rate and diminished attachment to extracellular matrix. These data are consistent with the rapid migration of BrdU labeled basal cells into the suprabasal compartment of EGFR deficient tumors and the premature cell cycle arrest as tumor cells enter the differentiating pool. Activation of the EGFR in squamous tumors causes tyrosine phosphorylation of PKC d and inactivation of its catalytic activity. Members of the Src family appear to be the proximal tyrosine kinases that phosphorylate PKC d. In tumor cells, Src and PKC d co-immunoprecipitate, and Src inhibitors prevent the association, inhibit PKC d tyrosine phosphorylation, and restore differentiation. Tyrosine mutants of PKC d implicate tyrosine 64 and 565 as targets for Src kinase phosphorylation and catalytic inactivation. The mitochondria of keratinocytes are a target for PKC d in normal keratinocytes. Activation of PKC d causes a decrease in mitochondrial membrane potential, activation of caspases and keratinocyte apoptosis. Inhibitors of mitochondrial electron transport can suppress this apoptotic response. Squamous tumor cells of mouse and human origin are susceptible to killing by overexpressing and activating PKC d using an adenoviral vector. Overexpression of PKC a in transgenic epidermis produces a marked inflammatory response and apoptosis when activated by phorbol esters. PKC a activation upregulates the expression of a number of chemokines and alters the expression of keratinocyte differentiation markers. These affects of PKC a can be prevented by a dominant-negative Fos vector suggesting they are mediated by AP-1 dependent transcriptional activity. Introduction of a ras oncogene into keratinocytes overexpressing PKC a enhances tumor growth over ras transformed wildtype keratinocytes. PKC also interacts with the PI3K/AKT cell survivial pathway. PKC activation prevents activation of AKT by IGF-1 receptor activation. Inhibition of PKC by pharmacologic agents enhances the protection of UV treated keratinocytes imposed by IGF-1.

Agency
National Institute of Health (NIH)
Institute
Division of Basic Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC004504-29
Application #
6558866
Study Section
(CCTP)
Project Start
Project End
Budget Start
Budget End
Support Year
29
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Pastore, Saveria; Mascia, Francesca (2008) Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin. Expert Rev Dermatol 3:525-527
Lichti, Ulrike; Anders, Joanna; Yuspa, Stuart H (2008) Isolation and short-term culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice. Nat Protoc 3:799-810
Suh, Kwang S; Mutoh, Michihiro; Mutoh, Tomoko et al. (2007) CLIC4 mediates and is required for Ca2+-induced keratinocyte differentiation. J Cell Sci 120:2631-40
Stepp, Mary Ann; Liu, Yueyuan; Pal-Ghosh, Sonali et al. (2007) Reduced migration, altered matrix and enhanced TGFbeta1 signaling are signatures of mouse keratinocytes lacking Sdc1. J Cell Sci 120:2851-63
Wolf, Ronald; Voscopoulos, Christopher J; FitzGerald, Peter C et al. (2006) The mouse S100A15 ortholog parallels genomic organization, structure, gene expression, and protein-processing pattern of the human S100A7/A15 subfamily during epidermal maturation. J Invest Dermatol 126:1600-8
Li, Luowei; Sampat, Keeran; Hu, Nancy et al. (2006) Protein kinase C negatively regulates Akt activity and modifies UVC-induced apoptosis in mouse keratinocytes. J Biol Chem 281:3237-43
Cataisson, Christophe; Pearson, Andrea J; Tsien, Margaret Z et al. (2006) CXCR2 ligands and G-CSF mediate PKCalpha-induced intraepidermal inflammation. J Clin Invest 116:2757-66
Shiio, Yuzuru; Suh, Kwang S; Lee, Hookeun et al. (2006) Quantitative proteomic analysis of myc-induced apoptosis: a direct role for Myc induction of the mitochondrial chloride ion channel, mtCLIC/CLIC4. J Biol Chem 281:2750-6
Boeshans, Karen M; Wolf, Ronald; Voscopoulos, Christopher et al. (2006) Purification, crystallization and preliminary X-ray diffraction of human S100A15. Acta Crystallograph Sect F Struct Biol Cryst Commun 62:467-70
Cataisson, Christophe; Pearson, Andrea J; Torgerson, Sara et al. (2005) Protein kinase C alpha-mediated chemotaxis of neutrophils requires NF-kappa B activity but is independent of TNF alpha signaling in mouse skin in vivo. J Immunol 174:1686-92

Showing the most recent 10 out of 19 publications